Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Basima Arous"'
Autor:
Basima Arous, Mohammad Amer Al-Mardini
Publikováno v:
Pharmaceutical Chemistry Journal. 52:573-581
Apixaban is a novel anticoagulant drug acting as a direct, selective and reversible inhibitor of coagulation factor Xa. The purpose of this work was to develop and validate a sensitive, stability-indicating LC-MS method for the analysis of apixaban a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9681444ca1863349031a30f9d0c8b4eb
https://doi.org/10.1007/s11094-018-1862-x
https://doi.org/10.1007/s11094-018-1862-x
Autor:
Basima Arous, Mohammad Amer Al-Mardini, Manal Daghestani, Francois Karabet, Fida Al-Lahham, Alyamama Al-Askar
Publikováno v:
Pharmaceutical Chemistry Journal. 52:483-490
The purpose of this work was to develop a sensitive and validated HPLC method for analysis of rivaroxaban and estimation of related impurities in parent drug substance and pharmaceutical dosage forms. The analysis was carried out on a Macherey-Nagel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be3373e234bab6fb897a6064fff8dcb1
https://doi.org/10.1007/s11094-018-1844-z
https://doi.org/10.1007/s11094-018-1844-z
A validated stability indicating thin layer chromatographic (TLC) and liquid chromatography coupled with mass spectrometry LC/MS methods were developed to analyze Rivaroxaban and its degradation products. Forced degradation studies under stress condi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93557eab8fb9b5655034701efc4d4005
https://eprints.kingston.ac.uk/id/eprint/40881/1/Ghazal-H-40881-AAM.pdf
https://eprints.kingston.ac.uk/id/eprint/40881/1/Ghazal-H-40881-AAM.pdf
Autor:
Mhd Amer Al-Mardini, Basima Arous
Publikováno v:
Research Journal of Pharmacy and Technology. 11:1119
Dabigatran is a novel anticoagulant drug acting as a direct and reversible thrombin inhibitor. The purpose of this work was to develop a sensitive and validated LC-MS method for the analysis of Dabigatran etexilate and estimation of its impurity prof
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10a84544a91e74f5c5f20043b95e4a2f
https://doi.org/10.5958/0974-360x.2018.00210.x
https://doi.org/10.5958/0974-360x.2018.00210.x